腹腔置管引流联合泼尼松治疗结核性腹膜炎疗效分析.docVIP

精品论文 参考文献 腹腔置管引流联合泼尼松治疗结核性腹膜炎疗效分析 于小云 　　（南充市嘉陵区妇幼保健院内科 四川南充 637000） 　　【摘要】目的：研究腹腔置入中心静脉导管引流腹水联合泼尼松治疗结核性腹膜炎的临床疗效。方法：将47例伴有大量腹水的结核性腹膜炎患者随机分为两组：治疗组24例，采用中心静脉导管置入腹腔引流腹水并口服泼尼松；对照组23例，采用常规腹腔腔穿刺抽腹水。两组均采用3HRZE/9HRE抗结核治疗方案。结果：治疗组腹水消失时间明显短于对照组，发生肠粘连、肠梗阻小于对照组，差异有统计学意义（P＜0.05），两组副反应无明显差异（Pgt;0.05）。结论：腹腔置管引流联合泼尼松治疗大量腹水的结核性腹膜炎疗效确切，副作用小，值得进一步推广。 　　【关键词】中心静脉导管 泼尼松 结核性腹膜炎 　　【中图分类号】R656.4+1 【文献标识码】A 【文章编号】2095-1752（2014）21-0251-02 　　The effect of central venous catheterition combined with prednisone treat tuberculous peritonitis 　　YU Xiao-yun 　　(Department of medcine , Mch hospital of JiaLing District,Nanchong 637000,Sichuan) 　　【Abstract】Objective To observe the effect of central venous catheterition combined with prednisone treat tuberculous peritonitis. Methods 47 tuberculous peritonitis patients were randomly divided into two groups,the treatment group received the treatment of depositing a central venous catheter in abdominal cavity cavity and taking prednisone.group B received the treatment of removing fluid from the cavity with abdominal centesis intermittently.both groups were gived regular anti-tuberculosis therapy of 3HRZE/9HRE. Result The incidenc of ankylenteron and abdomina adhesions is less in the treatment group, and the time of pleural effusion absorption was shorter in treatment group（Plt;0.05）.the incidenc of ill effect was no significant diffrence between the two groups(Pgt;0.05). Conclusion It is effective method to treat tuberculous peritonitis by central venous catheter combine prednisone, and ill effect little ,worth to further clinical investigation. 　　【Key words】Central venous catheter prednisone tuberculous peritonitis 　　结核性腹膜炎是由结核杆菌引起的腹膜慢性、弥漫性炎症，是临床常见的疾病之一，对于腹腔积液的患者，腹水处理不及时或不彻底是造成目前临床上各种腹腔及肠粘连甚至梗阻的主要原因[1]。 由于腹膜粘连、肥厚等病理改变较明显，致抗结核药物的渗透性下降，腹水持续存在的时间明显延长，严重影响临床治疗效果及预后，也是造成肠梗阻、肠穿孔的主要原因。因此，尽早彻底排尽腹水对治愈渗出性结核性腹膜炎，对防止肠粘连、梗阻及其它并发症至关重要。现将我院收治的以中心静脉导管置入腹腔引流腹水联合泼尼松治疗伴中至大量腹水的结核性腹膜炎进行疗效分析。 　　1 资料与方法 　　1.1 一般资料 4